Vivek Ramaswamy es un emprendedor y empresario que fundó Roivant Sciences GmbH, Roivant Sciences, Inc., Campus Venture Network, Inc. y Roivant Sciences Ltd. y que ha estado al frente de 10 empresas diferentes. En la actualidad, el Sr. Ramaswamy es Presidente Ejecutivo de Roivant Sciences Ltd., Presidente Ejecutivo de Roivant Sciences GmbH y Presidente Ejecutivo de Roivant Sciences, Inc. (ambas son filiales de Roivant Sciences Ltd.) y Presidente de Montes Archimedes Acquisition Corp. El Sr. Ramaswamy también forma parte del consejo de Sumitovant Biopharma, Inc. En su anterior carrera, el Sr. Ramaswamy fue presidente de Arbutus Biopharma Corp. y presidente de Arbutus Biopharma, Inc. (filial de Arbutus Biopharma Corp.), director de Sio Gene Therapies, Inc. y consejero delegado de Axovant Sciences, Inc. (filial de Sio Gene Therapies, Inc.), presidente de Campus Venture Network, Inc., analista de inversiones de QVT Financial LP y director de Myovant Sciences Ltd. Se graduó en la Facultad de Derecho de Yale y se licenció en el Harvard College.

Principales empresas

Strive Asset Management LLC Strive Asset Management LLC Investment ManagersFinance The company, co-founded by Vivek Ramaswamy and Anson Frericks in 2022, is based in Dublin, OH. Part of Strive Enterprises, Inc., Strive Asset Management LLC is a US-based asset management firm that aims to restore the voices of everyday citizens in the American economy by leading companies to prioritize excellence over politics. Strive Asset Management LLC plans to compete with the world's largest asset managers by launching index funds that promote excellence capitalism across corporate sectors. Matthew Cole has been the CEO of the company since 2022.

Presidente